Ruqin Chen, MB, on Lung Cancer Treated With Immune Checkpoint Inhibitors: Predicting Survival Outcomes

Posted: Friday, March 29, 2019

Ruqin Chen, MB, of the Mayo Clinic Florida, discusses the clinical and molecular features associated with good survival outcomes and those associated with poor prognoses in patients with lung cancer treated with immune checkpoint inhibitors.